Saturday 17 October 2026 Export RDY’s income statement to Excel — free account

Dr. Reddy's Laboratories Ltd

RDY Healthcare Drug Manufacturers Specialty & Generic

Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025. In the quarter to June 2026, revenue fell 14.4%, EPS fell 70.0%, free cash flow fell 143.4% and total debt rose 34.0%, each against the same quarter a year earlier.

13.05 0.15 +1.16%

Follow RDY

Alert me

Market cap: $10.7B
P/E: 32.9×
Fwd P/E: 24.3×
Dividend yield: 0.00%
F-score: 4/9
Altman Z: 5.26
Beneish M: −2.59
Dividend safety: 74/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	17.26	18.23	25.79	36.49
P/S ratio Full definition →		2.95	2.97	3.22	3.30
P/FCF ratio Full definition →		52.91	40.59	53.62	81.66
P/Operating CF Full definition →		68.88	99.07	77.38	(1,135.05)
P/B ratio Full definition →		2.86	2.79	2.84	2.78
Price to Tangible BV Full definition →		4.16	4.02	4.12	3.98
EV/Sales Full definition →		2.92	2.93	3.19	3.27
EV/EBITDA Full definition →		11.04	11.71	15.04	18.87
EV/Operating CF Full definition →		17.11	16.07	18.81	26.40
EV/FCF Full definition →		52.33	40.00	53.09	80.90
Quick Ratio Full definition →		1.11	1.18	1.13	1.16
Current Ratio Full definition →		1.85	1.88	1.80	1.90
Net Debt/EBITDA Full definition →		(0.50)	(0.78)	(4.36)	(1.07)
Debt/Assets Full definition →		10.81%	12.03%	13.34%	12.51%
Debt/Equity Full definition →		0.16	0.18	0.20	0.19
Asset Turnover Full definition →		0.68	0.66	0.60	0.57
Operating CF/Net income Full definition →		1.02	0.87	(13.83)	(0.21)
Capex/Depreciation Full definition →		(1.96)	(1.34)	(1.72)	(0.23)
Interest Coverage Full definition →		19.31	15.08	(2.99)	2.93
Research and Development Expense of Revenue Full definition →		7.04%	7.05%	7.22%	7.15%
Selling, General and Administrative Expense of Revenue Full definition →		30.02%	30.85%	39.21%	35.64%
Intangible Assets out of Total Assets Full definition →		0.21	0.20	0.20	0.20
Share Based Compensation of Revenue Full definition →		0.10%	0.10%	0.00%	0.12%
Graham Net Nets Full definition →		0.10	0.11	0.10	0.10
Graham Number Full definition →		9.45	9.33	7.67	6.83
Earnings Yield Full definition →		5.79%	5.48%	3.88%	2.74%
Free Cash Flow Yield Full definition →		1.89%	2.46%	1.86%	1.22%
Revenue per Share Full definition →		1.22	1.17	0.71	1.09
Operating CF per Share Full definition →		0.20	0.14	0.18	(0.01)
Capex per Share Full definition →		(0.13)	(0.09)	(0.11)	(0.02)
Free Cash Flow per Share Full definition →		0.07	0.05	0.07	(0.03)
Cash per Share Full definition →		0.95	1.11	1.13	1.10
Shareholders Equity per Share Full definition →		4.90	5.02	4.87	5.22
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.90	5.02	4.87	5.22
Free Cash Flow Full definition →		61.00	43.00	58.00	(23.00)
Working Capital Full definition →		1,448.00	1,550.00	1,432.00	1,501.00
Capital Expenditures Full definition →		(108.00)	(75.00)	(91.00)	(13.00)
Net Current Asset Value Full definition →		1,121.00	1,229.00	1,098.00	1,171.00
EV/EBIT Full definition →		13.96	15.10	21.18	29.99
Capex to Sales Full definition →		0.11	0.08	0.15	0.02
Price to Operating Income Full definition →		14.12	15.32	21.39	30.27
Other line items
Average Receivables Full definition →		1,054.50	1,113.50	1,068.50	1,086.00
Average Payables Full definition →		440.00	437.50	386.50	416.50
Average Inventory Full definition →		857.00	858.00	824.00	866.00
Average Assets Full definition →		5,834.00	5,944.50	5,973.50	6,069.00
Average Common Equity Full definition →		3,884.50	3,971.50	4,000.50	4,105.50

Fold the line items

Columns are period end dates

Stockrow Weekly